Avadel Pharmaceuticals (FRA:AWK) Days Sales Outstanding : 65.23 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Avadel Pharmaceuticals Days Sales Outstanding?

Avadel Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2024 was €32.2 Mil. Avadel Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was €45.1 Mil. Hence, Avadel Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2024 was 65.23.

The historical rank and industry rank for Avadel Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:AWK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.67 Med: 53.3 Max: 157.98
Current: 58.92

During the past 13 years, Avadel Pharmaceuticals's highest Days Sales Outstanding was 157.98. The lowest was 9.67. And the median was 53.30.

FRA:AWK's Days Sales Outstanding is ranked better than
62.71% of 968 companies
in the Drug Manufacturers industry
Industry Median: 71.165 vs FRA:AWK: 58.92

Avadel Pharmaceuticals's Days Sales Outstanding increased from Sep. 2023 (51.96) to Sep. 2024 (65.23).

Avadel Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Avadel Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avadel Pharmaceuticals Days Sales Outstanding Chart

Avadel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

59.63

148.18

157.97

Avadel Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															51.96	43.34	58.35	61.40	65.23

Competitive Comparison of Avadel Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Avadel Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avadel Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avadel Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Avadel Pharmaceuticals's Days Sales Outstanding falls into.

Avadel Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Avadel Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	11.098)	/	1 )	/	25.642	*	365
=	11.098					/	25.642	*	365
=	157.97

Avadel Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (31.007	+	33.429)	/	2 )	/	45.073	*	365 / 4
=	32.218					/	45.073	*	365 / 4
=	65.23

Avadel Pharmaceuticals (FRA:AWK) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Avadel Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Avadel Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Avadel Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avadel Pharmaceuticals PLC (FRA:AWK) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AVDL:USA AWK:Germany

Address

10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380

Website

https://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.